Skyrizi 600 mg concentrate for solution for infusion clinical trials

Investigating the safety, feasibility, and optimal dose of risankizumab-800CW for visualizing drug targeting in Inflammatory Bowel Disease

This study is looking at a new way to see how a medicine called Skyrizi works in people with Inflammatory Bowel Disease (IBD). It's checking if the medicine is safe, how much to give, and how well it helps doctors see inflammation inside the body.